New Strategy for Avoiding Waste and Improving Response for Highest Cost Therapies in Rheumatoid Arthritis
Read moreScipher Medicine Announces Publication of Clinical Study Validating PrismRA, a Blood Test Predicting Non-Response to TNF Inhibitor Therapies in Patients with Rheumatoid Arthritis
Read morePandemic versus pandemonium: fighting on two fronts
Read moreCOVID-19 might be bitter medicine for what ails AI investing
Read moreCoronavirus: AI steps up in battle against Covid-19
Read moreScipher Medicine has developed a blood test expected to save payers billions each year
Read moreDefining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling
Read moreScipher: Decoding Drug Response From Protein Interactions
Read moreGetting Personal With Precision Medicine
Read moreBringing Precision Medicine to Autoimmune Diseases
Read moreHow Precision Medicine Can Change the Drug Pricing Conversation
Read moreHow A Blood Test Can Disrupt A $20B Market
Read more